MetBalance test: Monitor your metabolic health and revolutionize the way you take care of yourself
In the modern era, concern for health and the prevention of non-communicable diseases has reached alarming proportions. As sedentary lifestyles, unhealthy diets, and chronic stress become more common, non-communicable diseases like type 2 diabetes, cardiovascular diseases, and obesity have emerged as significant medical challenges. However, in this context of concern, there has arisen a need […]
KICK-OFF HARMONI
In the following 3 years, Biosfer Teslab will be coordinating a consortium of companies and research centers in the framework of the project HARMONi: HARnessing the power of MultiOmics: towards the generation of Novel & Innovative diagnostic tools to improve cardiovascular risk prediction. This project will be funded under the call for Projects in public-private […]
Metabolomics and Sexual Reproductive Health: An Innovative Approach for Research and Treatment
The Marató de TV3 has announced that the upcoming edition, scheduled for December 17, 2023, will focus on Sexual and Reproductive Health (SSIR), a crucial theme impacting millions in Catalonia and globally. In this context, exploring innovative approaches in research is imperative, and metabolomics emerges as a promising tool to advance our understanding and treatment […]
Metabolomics Unveiling: A NMR Perspective on HIV Research and Personalized Therapeutics
Nuclear Magnetic Resonance (NMR) metabolomics emerges as a promising tool in HIV research due to its ability to provide a detailed insight into molecular changes in the body. By studying metabolomic profiles in individuals affected by HIV, NMR enables the identification of specific metabolic alterations associated with the infection. This approach not only facilitates the […]
Biosfer Teslab joins the charity run ‘Lliga’t a la Vida’ to combat cancer
In an effort to contribute to the fight against cancer, Biosfer Teslab has actively participated in ‘Lliga’t a la Vida,’ an exciting charity run that aims to raise funds and bring visibility to this devastating disease. ‘Lliga’t a la Vida-Trail’ was born with the enthusiasm of merging a love for sports with solidarity. In collaboration […]
Glycoproteins: Emerging Markers of Inflammation Independent of Cardiovascular Risk
Cardiovascular events occur despite the control of conventional risk factors. Inflammation plays numerous roles in the pathogenesis of atherosclerotic cardiovascular disease. As an alternative to traditional inflammatory markers, new biomarkers of systemic inflammation, including Glyc-A and Glyc-B measured by nuclear magnetic resonance (NMR), have been explored. Especially, the concentration of Glyc-A has been associated as […]
What is metabolomics and how is it applied in diabetes?
Metabolomic profiling involves identifying intermediary molecules and end-products of metabolism, encompassing lipids, lipoproteins, fatty acid variants, amino acids, and glycoprotein acetyls. This approach holds promise for discovering novel biomarkers indicative of disease risk and offers fresh perspectives on molecular mechanisms, biological processes, and implicated disease pathways. Diabetes, affecting over 500 million people in 2021, stands […]
Biosfer Teslab at the event “Empowering the Future We Want”
On Monday, October 16, 2023, our CEO Núria Amigó participated in the event “Empowering the Future We Want” alongside Jose Bayon Lopez, CEO of ENISA, and Juan Merodio. The purpose of this event was to introduce the #SpainUpNation program. ENISA, the National Innovation Company, is a public entity under the Ministry of Industry, Commerce, and […]
Discordance between LDL-C levels and LDL particle number
The size of LDL lipoproteins varies and is dependent on the lipid content they carry inside, which in turn influences the particle density. LDL cholesterol (LDL-c) refers to the concentration or amount of cholesterol transported by low-density lipoproteins (LDL). LDL particles are the carriers of LDL cholesterol, and within LDL particles, there are differences in […]
Cardiovascular Disease: Beyond LDL Cholesterol
Cardiovascular disease (CVD) claims the lives of over 4 million people in Europe every year. Dyslipidemia, a disorder characterized by abnormal blood lipid levels, is one of the most significant risk factors for the development of CVD. Specifically, LDL cholesterol plays a central role in the relationship between cardiovascular disease and dyslipidemia. However, a high […]
